Results 191 to 200 of about 80,027 (384)
Phenotyping patients with chronic obstructive pulmonary disease and heart failure
Central illustration. Abbreviations: ACEi, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; ARNi, angiotensin‐receptor‐neprilysin inhibitor; CI, confidence interval; COPD, chronic obstructive pulmonary disease; CRT, cardiac resynchronization therapy; CV, cardiovascular; EF, ejection fraction; eGFR, estimated glomerular ...
Peter Moritz Becher+12 more
wiley +1 more source
Essential hypertension, dementia, and antihypertensive therapy in geriatric patients
The review summarizes the current views on the pathogenesis of dementia and the significance of blood pressure levels for its development. The present status of the prevention of cognitive disorders and dementia is detailed in the use of antihypertensive
Zhanna Davidovna Kobalava+5 more
doaj
eGFR slope as predictor of mortality in heart failure patients
Abstract Aims Heart failure (HF) leads to an imbalance between heart and kidney function, resulting in poor outcomes. However, the prognostic significance of the estimated glomerular filtration rate (eGFR) trajectory in HF patients remains unclear. We analysed electronic health records (EHRs) of real‐world HF patients, assessing eGFR trajectories and ...
Sofie Verstreken+10 more
wiley +1 more source
POST-ISCHEMIC TREATMENT WITH CANDESARTAN PROTECTS FROM CEREBRAL ISCHEMIC REPERFUSION INJURY IN NORMOTENSIVE RAT [PDF]
Large body of evidences has indicated that the renin – angiotensin system (RAS) and its effector peptide Angiotensin II may be involved in the pathophysiology of stroke.
نوری, محمد+1 more
core
Comparative performance of 7 risk prediction indices in patients hospitalized for heart failure. In this cohort of 1206 patients, the LENT index offered the greatest discrimination, calibration, and overall accuracy in predicting 30‐day composite all‐cause mortality or readmission following hospitalization for heart failure.
Tauben Averbuch+8 more
wiley +1 more source
Abstract Aims Immune checkpoint inhibitors (ICI) are the cornerstone of modern oncology; however, side effects such as ICI‐related myocarditis (irM) can be fatal. Recently, Bonaca proposed criteria for irM; however, it is unknown if they correlate well with cardiovascular (CV) ICI‐related adverse events.
Lorenzo Braghieri+12 more
wiley +1 more source
Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Antagonists, and Symptomless Dysphagia [PDF]
Tadashi Arai+6 more
openalex +3 more sources
In vitro pharmacology of U-97018, a novel AT1 subtype angiotensin II receptor antagonist.
Osamu Morita+4 more
openalex +1 more source